FDA Investigator: John P. Mistler
- John P. Mistler first started conducting FDA inspections in 2014, with the last inspection in 2023. Over that time, John P. Mistler has conducted 73 inspections at 66 companies across 69 sites.
Get John Mistler's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Pharmaceuticals, Windsor | October 2023
Available Now - $199
John P. Mistler
Human Drugs Form 483
FDA 483 Bayer Weimar und . KG, Weimar | September 2019
Available Now - $199
John P. Mistler
Human Drug Form 483
FDA 483 Analytical Lab Group, East Coast, Acton | Jan 2019
Available Now - $199
John P. Mistler
Human Drug Form 483
FDA 483 Johnson Memorial Cancer Center, Enfield | Oct 2018
Available Now - $199
John P. Mistler
Human Drug Form 483
FDA 483 Berkshire Sterile Manufacturing, Lee | April 2018
Available Now - $199
John P. Mistler
Human Drug Form 483
FDA 483 Lynnfield Drug, . dba Freedom Fertility Pharm | 2018
Available Now - $199
John P. Mistler
Human Drug Form 483
FDA 483 Mytilini Enterprises dba Bedford Pharmacy | Aug 2017
Available Now - $199
John P. Mistler
Human Drug Form 483
483 Response Mytilini Enterprises dba Bedford Pharmac | 2017
Available Now - $299
John P. Mistler
Human Drug Form 483
FDA 483 Beacon Prescriptions, Southington | October 2016
Available Now - $199
John P. Mistler
Human Drug Form 483
FDA 483 Anderson Holdings, Nashua | February 2016
Available Now - $199
John P. Mistler
Human Drug Form 483
FDA 483 Genoa, a QoL Healthcare, Norwich | October 2015
Available Now - $199
John P. Mistler
Human Drug Form 483
FDA 483 MANCHESTER VA MEDICAL CENTER, Manchester | 2020
Out-of-stock
John P. Mistler
Human Drug Form 483
FDA 483 Avista Pharma Solutions, Inc. dba Cambrex, Agawam | 2019
Out-of-stock
John P. Mistler
Human Drug Form 483
FDA 483 Compounded Solutions in Pharmacy, Monroe | 2019
Out-of-stock
John P. Mistler
Human Drug Form 483
FDA 483 Mylan Pharmaceuticals Inc, Morgantown | 2019
Out-of-stock
John P. Mistler
Human Drug Form 483
FDA 483 The General Hospital Corporation, Boston | 2019
Out-of-stock
John P. Mistler
Human Drug Form 483
FDA 483 Atlantic Animal Health, Inc. dba Squire Laboratories, Revere | 2019
Out-of-stock
John P. Mistler
Animal Drugs & Feed Form 483
FDA 483 Global Calcium Pvt. Limited, Hosur | 2019
Out-of-stock
John P. Mistler
Human Drug Form 483
FDA 483 Fresenius Kabi Compounding, LLC, Canton | 2018
Out-of-stock
John P. Mistler
Human Drug Form 483
FDA 483 ImmuCell Corporation, Portland | 2018
Out-of-stock
John P. Mistler
Animal Drugs & Feed Form 483
Co-Investigators (22)
- Jonah S. Ufferfilge, FDA Investigator
- Erik W. Koester, FDA Investigator
- Samir C. Gala, FDA Investigator
- Tamil Arasu, FDA Investigator
- Sean R. Marcsisin, FDA Investigator
- Guerlain Ulysse, FDA Investigator
- Thomas J. Arista, FDA Investigator
- Robert J. Martin, FDA Investigator
- Christopher Janik, FDA Investigator
- Victoria M. Daddeo, FDA Investigator
- Richard A. Abate, FDA Investigator
- Maotang Zhou, FDA Investigator
- Nealie C. Newberger, FDA Investigator
- Danielle Pearson, FDA Investigator
- Michelle A. Marsh, FDA Investigator
- Lashanda M. Long, FDA Investigator
- Dien N. Nguyen, FDA Investigator
- Stacey S. Degarmo, FDA Investigator
- Juanita P. Versace, FDA Investigator
- Mary-Jeanet McGarry, FDA Investigator
- Philip F. Istafanos, FDA Investigator
- Jayaleka J. Amarasinghe, FDA Investigator